Bexarotene
- Product NDC
- 42291-072
- 11-digit product format
- 422910072
- Labeler code
- 42291
- Product ID
- 42291-072_41163fef-69b8-4e09-e063-6294a90ac8ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bexarotene
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA210105
- Marketing category
- ANDA
- Marketing start
- 2023-04-14
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bexarotene
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEXAROTENE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A61RXM4375 |
| Rxcui | 308725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-072-01 | Bexarotene | 100 in 1 BOTTLE | CAPSULE | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-072 | BEXAROTENE CAPSULE [AVKARE] | 1 | Current NDC, 1 package rows | 20230415_f9514265-6e2c-9030-e053-6394a90aa04b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42291-072-01 | 42291007201 | 100 CAPSULE in 1 BOTTLE (42291-072-01) | 100 capsule | 2023-04-14 | No | No | Current |